Stem Cells Assisted Cancellous Bone Graft Versus Stem Cells with Demineralized Bone Matrix for Alveolar Cleft Reconstruction | ||
| The Egyptian Journal of Plastic and Reconstructive Surgery | ||
| Article 14, Volume 42, Issue 1, January 2018, Pages 93-101 PDF (95 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejprs.2018.215070 | ||
| Authors | ||
| Helmy A Soliman* 1; Hossam El Din A Ismail2; Omar O Shouman2; Ahmed M Bahaa El Din2; Mohamed R El Hadidy2 | ||
| 1The Department of Plastic Surgery Mataria Teaching Hospital , Cairo | ||
| 2The Department of Plastic Surgery, Faculty of Medicine, Mansoura University, Egypt | ||
| Abstract | ||
| Background: Although different bone graft materials have been suggested in the literatures for alveolar cleft reconstruction including autogenous, allogenic, xenogenic, and alloplastic grafts, Autogenous bone graft either from the iliac crest or the tibial plateau remains the gold standard against which other graft materials are evaluated. However, the procedure is invasive and associated with a potential risk of early complications such as bleeding, pain, infection, fracture and/or late complications such as chronic pain, scarring, paresthesia and gait abnormalities. Moreover, its failure rate is about 15%. Objectives: To assess the efficacy of using adipose derived stem cells (ASCs) in alveolar cleft reconstruction; whether added to the cancellous bone or used with demineralized bone matrix scaffold; in comparison to the conventional iliac crest bone grafting (ICBG). Patients and Methods: 24 patients underwent alveolar cleft reconstruction at the age of mixed dentition over a 3- years period; three of them had two grafted sites (bilateral cleft cases) giving an overall total of 27 grafted sites assessed during this study. Their mean age was 11.9 years and their mean postoperative follow-up was 11.7 months. Of these, 9 constituted the ICBG group (standard group), 10 constituted the ACSs with ICBG scaffold (ASCs/ICBG) group, whereas the remaining 8 made up ACSs with DBM (ASCs/DBM) group. Results were assessed by rating the radiographs obtained 6 months postoperatively according to Bergland scale. Results: Alveolar cleft repairs using cancellous bone only (ICBG group) were 77.8 percent successful, alveolar cleft repairs using cancellous bone enhanced with ASCs (ASCs/ ICBG group) were 90 percent successful, and alveolar cleft repairs using DBM enhanced with ASCs (ASCs/DBM group) were 50 percent successful, but there were no significant statistical difference between the groups. ASCs/DBM group < br />shows significantly shorter operative time, and higher cleft site infection rates. Conclusion: Using ASCs whether with DBM or ICBG is not significantly better than the conventional method, while using DBM significantly reduced operative time, but associated with higher risk of infection. | ||
| Keywords | ||
| Alveolar cleft reconstruction; Stem cells; Demineralized bone matrix | ||
| References | ||
|
Horswell B.B. and Henderson J.M.: Secondary osteoplasty of the alveolar cleft defect. J. Oral Maxillofac. Surg., 61 (9): 1082-1090, 2003. 2- Jia Y.L., Fu M.K. and Ma L.: Long-term outcome of secondary alveolar bone grafting in patients with various types of cleft. Br. J. Oral Maxillofac. Surg., 44: 308-312, 2006. 3- Cohen M., Figueroa A.A., Haviv Y., et al.: Iliac versus cranial bone for secondary grafting of residual alveolar clefts. Plast Reconstr Surg., 87: 423-427, 1991. 4- Gimbel M., Ashley R.K., Sisodia M., et al.: Repair of alveolar cleft defects: Reduced morbidity with bone marrow stem cells in a resorbable matrix. J. Craniofac. Surg., 18 (4): 895-901, 2007. 5- Moreau J.L., Caccamese J.F., Coletti D.P., et al.: Tissue engineering solutions for cleft palates. J. Oral Maxillofac. Surg., 65 (12): 2503-11, 2007. 6- Schultze-Mosgau S., Nkenke E., Schlegel A.K., et al.: Analysis of bone resorption after secondary alveolar cleft bone grafts before and after canine eruption in connection with orthodontic gap closure or prosthodontic treatment. J. Oral Maxillofac. Surg., 61 (11): 1245-1253, 2003. 7- Viktot T., Zach J., Maryam K., et al.: Stem cells, growth factors and scaffolds in craniofacial regenerative medicine. Genes & Diseases J., 3 (1): 56-71, 2016. 8- Filho O., Ozawa T., Bachega C., et al.: Reconstruction of alveolar cleft with allogenous bone graft: Clinical considerations. Dent. Press J. Orthod, 18 (6): 138-147, 2013. 9- Tanimoto K., Sumi K., Yoshioka M., et al.: Experimental tooth movement into new bone area regenerated by use of bone marrow-derived mesenchymal stem cells. Cleft 100 Vol. 42, No. 1 / Stem Cells Assisted Cancellous Bone Graft Versus Stem Cells Palate Craniofac. J., 19: doi: http://dx.doi.org/10.1597/12- 232, 2013. 10- Zhang D., Chu F., Yang Y., et al.: Orthodontic tooth movement in alveolar cleft repaired with a tissue engineering bone: An experimental study in dogs. Tissue Eng. Part A, 17 (9-10): 1313-1325, 2011. 11- Pourebrahim N., Hashemibeni B., Shahnaseri S., et al.: A comparison of tissue-engineered bone from adiposederived stem cell with autogenous bone repair in maxillary alveolar cleft model in dogs. Int. J. Oral Maxillofac. Surg., 42 (5): 562-570, 2013. 12- Korn P., Schulz M.C., Range U., et al.: Efficacy of tissue engineered bone grafts containing mesenchymal stromal cells for cleft alveolar osteoplasty in a rat model. J. Craniomaxillofac. Surg., 4. pii: S1010 5182(14)00090- 0, 2014. 13- Pradel W., Tausche E., Gollogly J., et al.: Spontaneous tooth eruption after alveolar cleft osteoplasty using tissueengineered bone: A case report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod J., 105 (4): 440-444, 2008. 14- Behnia H., Khojasteh A., Soleimani M., et al.: Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: A preliminary report. J. Craniomaxillofac. Surg., 40 (1): 2-7, 2012. 15- Stanko P., Mracna J., Stebel A., et al.: Mesenchymal stem cells - a promising perspective in the orofacial cleft surgery. Bratisl Lek Listy, 114 (2): 50-52, 2013. 16- Coleman S.R.: Structural fat grafts: The ideal filler?, Clin. Plast. Surg., 28: 111e9, 2001. 17- Bergland O., Semb G., abyholm F., et al.: Secondary bone grafting and orthodontic treatment in patients with bilateral complete clefts of the lip. Annals of Plastic Surgery J., 17 (6): 460-474, 1986. 18- Rawashdeh M. and Telfah H.: Secondary alveolar bone grafting: The dilemma of donor site selection and morbidity. Br. J. Oral Maxillofac. Surg., 46 (8): 665-670, 2008. 19- Ochs M.: Alveolar cleft bone grafting (Part II): Secondary bone grafting. J. Oral Maxillofac. Surg., 54 (1): 83-88, 1996. 20- Oppenheimer A.J., Mesa J. and Buchman S.R.: Current and emerging basic science concepts in bone biology: implications in craniofacial surgery. Craniofac. Surg. J., 23: 30-36, 2012. 21- Zuk P., Zhu M., Mizuno H., et al.: Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. J., 7: 211-218, 2001. 22- Yoshimura K., Sato K., Aoi N., et al.: Cell-assisted lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells. Aesthetic Plast. Surg. J., 32: 48-55, 2008. 23- Hibi H., Yamada Y., Ueda M., et al.: Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int. J. Oral Maxillofac. Surg., 35 (6): 551-555, 2006. 24- Peng L., Jia Z., Yin X., et al.: Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Cartilage, and Adipose Tissue. Stem Cells and Development J., 17: 761-774, 2008. 25- Rubio D., Garcia-Castro J., Bernad A., et al.: Spontaneous human adult stem cell transformation. Cancer Res. J., 65 (8): 3035-3039, 2005. 26- Lu F., Mizuno H., Uyasal C., et al.: Improved viability of random pattern skin flaps through the use of adipose derived stem cells. Plast. Reconstr. Surg. J., 121: 50-58, 2008. 27- Guasti L., Prasongchean W., Kleftouris G., et al.: High plasticity of pediatric adipose tissue derived stem cells: Too much for selective skeletogenic differentiation? Stem Cells Transl Med., 1 (5): 384-395, 2012. 28- Yang P., Huang X., Wang C., et al.: Repair of bone defects using a new biomimetic construction fabricated by adiposederived stem cells, collagen I, and porous beta-tricalcium phosphate scaffolds. Exp. Biol. Med. (Maywood), 238 (12): 1331-1343, 2013. 29-. Daei-Farshbaf N., Ardeshirylajimi A., Seyedjafari E., et al.: Bioceramic-collagen scaffolds loaded with human adipose-tissue derived stem cells for bone tissue engineering, 41 (2): 741-749, 2014. 30- Benazzo F., Botta L., Scaffino M.F., et al.: Trabecular titanium can induce in vitro osteogenic differentiation of human adipose derived stem cells without osteogenic factors. J. Biomed Mater Res. A, 102 (7): 2061-2071, 2014. 31- Lendeckel S., Jödicke A., Christophis P., et al.: Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report. J. Craniomaxillofac. Surg., 32 (6): 370-373, 2004. 32- Cameron S., Francis M., Sheila S., et al.: rhBMP-2 with a demineralized bone matrix scaffold versus autologous iliac crest bone graft for alveolar cleft reconstruction. Plast. Reconstr. Surg. J., 131 (5): 1107-1115, 2013. 33- Sivak W., Macisaac Z., Rottgers S., et al.: Management of failed alveolar bone grafts: Improved outcomes and decreased morbidity with allograft alone. Plast. Reconstr. Surg. J., 133: 345-354, 2014. 34- Macisaac Z., Rottgers S., Davit A., et al.: Alveolar reconstruction in cleft patients: decreased morbidity and improved outcomes with supplemental demineralized bone matrix and cancellous allograft. Plast. Reconstr. Surg. J., 130: 625-632, 2012. 35- Louis J., Murakami H., Kim H., et al.: Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion. Spine J., 29: 360-366, 2004. 36- Kom P., Schulz M., Range U., et al.: Efficacy of tissue engineered bone grafts containing mesenchymal stromal cells for cleft alveolar osteoplasty in a rat model. J. Craniomaxillofac. Surg., 42 (7): 1277-1285, 2014. 37- Yuanzheng C., Yan G., Ting L., et al.: Enhancement of the repair of dog alveolar cleft by an autologous iliac bone, bone marrow-derived mesenchymal stem cell, and platelet-rich fibrin mixture. Plast. Reconstr. Surg. J., 135 (5): 1404-1427, 2015. 38- Benliday, Tatil U., Kurkcu M., et al.: Comparison of bovine-derived hydroxyapatite and autogenous bone for secondary alveolar bone grafting in patients with alveolar clefts. Oral Maxillofac. Surg. J., 1: 95-102, 2012. Egypt, J. Plast. Reconstr. Surg., January 2018 101 39- De Ruiter A., Janssen N., van Es R., et al.: Micro structured beta-tricalcium phosphate for repair of the alveolar cleft in cleft lip and palate patients: A pilot study. Cleft Palate Craniofac. J., 52 (3): 336-340, 2015. 40- Tuli S.M. and Singh A.D.: The osteoninductive property of decalcified bone matrix. An experimental study. J. Bone Joint Surg., 60: 116-123, 1978. 41- Marukawa E., Oshina H., Iino G., et al.: Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft. J. Craniomaxillofac. Surg., 39 (4): 278-283, 2011. 42- Alonso N., Tanikawa D.Y., Freitas Rda S., et al.: Evaluation of maxillary alveolar reconstruction using a resorbable collagen sponge with recombinant human bone morphogenetic protein-2 in cleft lip and palate patients. Tissue Eng. Part C Methods, 16 (5): 1183-1192, 2010. 43- Backly R.M., Zaky S.H., Canciani B., et al.: Platelet rich plasma enhances osteoconductive properties of a hydroxyapatite- ß-tricalcium phosphate scaffold (Skelite) for late healing of critical size rabbit calvarial defects. J. Craniomaxillofac. Surg., 42 (5e): 70-79, 2014. 44- Dutra C.E., Pereira M.M., Serakides R., et al.: In vivo evaluation of bioactive glass foams associated with platelet- rich plasma in bone defects. J. Tissue Eng. Regen. Med., 2 (4): 221-228, 2008. 45- Luaces-Rey R., Arenaz-Búa J., Lopez-Cedrún-Cembranos J.L., et al.: Is PRP useful in alveolar cleft reconstruction? Platelet-rich plasma in secondary alveoloplasty. Med. Oral Patol. Oral Cir. Bucal, 15 (4e): 619-623, 2010. 46- Canan L.W., da Silva Freitas R., Alonso N., et al.: Human bone morphogenetic protein-2 use for maxillary reconstruction in cleft lip and palate patients. J. Craniofac. Surg., 23 (6): 1627-1633, 2012. 47- Fallucco M.A. and Carstens M.H.: Primary reconstruction of alveolar clefts using recombinant human bone morphogenic protein-2: Clinical and radiographic outcomes. J. Craniofac. Surg., 2: 1759-1764, 2009. 48- Neovius E., Lemberger M., Docherty A.C., et al.: Alveolar bone healing accompanied by severe swelling in cleft children treated with bone morphogenetic protein-2 delivered by hydrogel. J. Plast. Reconstr. Aesthet. Surg., 66 (1): 37-42, 2013. 49- Dickinson B., Ashley B., Wasson R., et al.: Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast. Reconstr. Surg. J., 121 (1): 209-217, 2008. 50- Ananth S., Murthy M., James A., et al.: Secondary alveolar bone grafting: An outcome analysis. Can J. Plast. Surg., 14 (3): 172-174, 2006. 51- Felstead A.M., Deacom S. and Revington P.: The outcome for secondary alveolar bone grafting in the South West UK region post-CSAG. Cleft Palate Craniofac. J., 47 (4): 359-362, 2010. | ||
|
Statistics Article View: 210 PDF Download: 294 |
||
